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Introduction
Cellular development is controlled in at least two different 
ways: by intracellular signal transduction pathways, and by 
external signals from cells in close vicinity. these extracellu-
lar signals are often growth factors secreted from neighbor-
ing cells, which comprise the “niche”, a specialized cellular 
microenvironment [1–3]. there is considerable evidence 
that, in cell types of the niche, an exceedingly wide diversity 
of cellular communication signals controlling developmen-
tal processes, like neurogenesis or gliogenesis, is mediated 
via receptor tyrosine kinases (rtKs) and their ligands [4–
6]. among those rtKs are the vascular endothelial growth 
factor receptors (veGFrs), which were originally identi-
fied by their crucial role in development, maintenance and 
function of the vascular system [7–9]. these rtKs bind the 
members of the veGF growth factor family, which contains 
six different homologues of dimeric glycoproteins, namely 
veGF-a–e, and placenta growth factor (PlGF) [10, 11]. we 
and others have shown that veGF-a, -B and -C exert versa-
tile effects within the mammalian brain and stimulate neu-
ral cell proliferation, migration, differentiation and survival 
during development and in the adult [12–24]. In addition, 
neuronal cell survival-promoting properties of veGF-a, -B, 
-C in central nervous system (CNS) pathologies, like stroke, 
Parkinson’s disease and amyotrophic lateral sclerosis 
(alS), have been described in numerous studies in recent 
years (reviewed [25–28]). thus, the veGF/veGFr-system 
is a promising therapeutic target for various CNS diseases 
and insults. unfortunately, its role in both the vascular and 
the nervous system  opens the door for detrimental side 
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effects, like overriding endothelial cell growth or increased 
vascular leakage, leading to edema [29, 30].
throughout life, vascular cells are close to CNS germinal 
zones and neural stem cells (NSCs), and neural precursor 
cells (NPCs) are always found within an angiogenic com-
partment [3, 31–33]. as the definition between NSCs and 
NPCs is not always identically used in the literature, we 
here use the term NS/PCs to cover both cell types. In the 
last decade, much effort has been expended to distinguish 
direct and indirect effects of the veGF family members 
on CNS cells, especially on neurons, to circumvent these 
undesired outcomes of veGF-based therapies. we and oth-
ers have recently shown that veGFr-1 and -2 are spatially 
and temporally expressed differently in the nervous system 
and carry out distinct roles within the CNS under physi-
ological and pathological conditions (see sections below). 
these findings are of utmost importance as they provide the 
opportunity for the fine-tuning of therapeutic interventions 
in CNS protection and regeneration. therefore, this review 
aims to illustrate the functional diversity of veGFrs in the 
nervous system during brain development and maintenance 
under physiological conditions throughout life.
The VEGFR-1 and -2 and their ligands
the main receptors for growth factors of the veGF family 
are the rtKs: veGFr-1 (fms-related tyrosine kinase-1; Flt-
1) [7, 8], and veGFr-2 (fetal liver kinase 1; Flk-1) [9] and 
veGFr-3 (fms-related tyrosine kinase-4; Flt-4) [34, 35]. 
veGFr-1, -2 and -3 are typical rtKs, which are composed 
of an extracellular immunoglobulin-like domain, a trans-
membrane domain, and an intracellular split tK domain. 
ligand-binding to veGFrs induces receptor homodimeri-
zation, followed by kinase activation and autophosphoryla-
tion of specific tyrosine residues, which in turn initiate mul-
tiple downstream signaling pathways [10, 11].
this review focuses on the divergent roles of veGFr-1 
and -2. the most well-studied ligand of the veGF family, 
veGF-a, acts predominantly through veGFr-1 and -2 on 
neural and endothelial cells. Besides veGF-a, veGF-B 
and PlGF bind to veGFr-1 and veGFr-2 binds veGF-C 
and veGF-D [10, 11]. veGFr-3, veGF-C and –D will not 
be described in detail in this article, but in other articles of 
this issue. For a recent detailed review of veGFr signaling 
cascades, see Koch and Claesson-welsh [36].
the veGFr-1 and -2
veGFr-1 expression, like veGF-a, is inducible by hypoxia 
owing to a binding site for a hypoxia-inducible factor-1α 
(hIF-1α) in the veGFr-1 promoter region. veGFr-1 
occurs in two isoforms: a membrane-bound form and a 
shortened soluble form (sveGFr-1). the shortened form 
lacks the intracellular tK domain and is therefore incapa-
ble of intracellulary transduction of a veGF-signal. this 
soluble form appears to act chiefly as a ligand-trap, thus 
having regulatory consequences for veGF-mediated effects 
through other receptors. (reviewed [36, 37]). Overexpression 
of sveGFr-1 reduces the binding of veGF-a to veGFr-2 
and thereby diminishes veGFr-2 signaling. this could be 
either indirectly by sequestering of the ligand or directly by 
formation of veGFr-1/veGFr-2 heterodimers [38–40].
In spite of its higher binding affinity to veGF-a  com-
pared to veGFr-2, veGFr-1 shows poor autophospho-
rylation of the tK domain [41]. however, intracellular 
downstream target molecules of veGFr-1 have been 
identified. among them are phospholipase-Cγ (PlCγ), p38 
mitogen-activated protein kinase (p38 MaPK), p85 phosph-
oinositide-3-kinase (p85 PI3K), and growth factor receptor-
bound-2 (Grb-2) [37, 42, 43]. In vitro, veGFr-1 seems to 
be directly involved in the control of endothelial cell migra-
tion, as the inhibition of veGFr-1 in human umbilical vein 
endothelial cells (huveCs) blocks their migration, but 
does not inhibit veGF-a-induced proliferation. veGFr-1 
affects endothelial cell migration by modulation of the reor-
ganization of actin filaments, favorably by p38 MaPK and 
Paxillin activation [44].
On vascular processes, veGFr-1 seems to have an 
essential inhibitory role, since embryos that are homozy-
gous for veGFr-1-null mutation die early in embryonic 
development [embryonic day (e) 8.5] due to a disorgan-
ized vasculature with an elevated number of endothelial 
cells and overgrowth of blood vessels [45, 46]. this effect 
is subsequent to an increased mesenchymal–hemangioblast 
transition [47]. In line with this, transgenic mice in which 
the transmembrane domain and the intracellular domain of 
the veGFr-1 are deleted display frequent embryonic death 
due to decreased development of the vasculature [48]. In 
contrast, the exclusive deletion of the intracellular signaling 
domain (veGFr-1-tK−/− mice) does not result either in 
embryonic lethality or in an obvious severe phenotype [49]. 
Nevertheless, veGFr-1 signaling has been shown to play a 
role under certain pathological conditions, since pathologi-
cal angiogenesis, e.g., tumor angiogenesis, is deteriorated 
when overexpressing the specific veGFr-1 ligand PlGF-2 
[50]. Moreover, in the brain of adult veGFr-1-tK−/− mice, 
we found an increased level of veGF-a protein, which in 
turn enhanced olfactory neurogenesis and NPC migration 
[16]. Yet, the mechanism how veGFr-1 signaling influ-
ences the amount of veGF-a is still unclear.
Furthermore, veGFr-1 seems to be important for the 
recruitment of veGF to the membrane, as mice that express 
solely the soluble form of veGFr-1 show high early 
embryonic lethality with a phenotype similar to the com-
plete veGFr-1−/− knock-out mouse [48].Brain homeostasis
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veGFr-2 is the major mediator of veGF-a-mediated 
trophic effects in the vascular system. veGFr-2 signal 
transduction regulates the proliferation, migration and sur-
vival of endothelial cells and mediates signals increasing 
vascular permeability in response to veGF-a (reviewed 
[27, 28, 51]). Furthermore, veGFr-2 promotes veGF-C-
induced lymphangiogenesis. veGFr-2 knock-out mice fail 
to develop blood islands, and do not form a proper vascu-
lar system, leading to early embryonic death between e8.5 
and 9.5 [52, 53]. unlike veGFr-1 and veGF-a, veGFr-2 
expression is not regulated by hypoxia, but is upregulated 
by veGF-a [54].
Similar to the vascular system, in the CNS most of 
the trophic effects of veGF-a have also been ascribed to 
veGFr-2 signaling. veGFr-2 has a high kinase activity 
and activates several downstream pathways, like the PI3-
Kinase/-pathway or PlC-γ-pathway. those pathways trig-
ger proliferation and diminish apoptosis of endothelial and 
neural cells. veGFr-2 signaling further promotes prolifera-
tion, migration and neuronal differentiation of NPCs (see 
sections below for details).
Similar to sveGFr-1, a truncated soluble form of 
veGFr-2 (sveGFr-2) occurs physiologically and func-
tions as an endogenous antagonist of veGF-C, negatively 
regulating, e.g., lymphangiogenesis [51]. astonishingly, 
native sveGFr-2 has a poor affinity to veGF-a and lacks 
anti-hemangiogenic effects antagonizing veGF-a [51].
veGFr-1 and -2 show additional binding affinities to 
non-tK receptors Neuropilin (Nrp)-1 and Nrp-2, which 
are likewise receptors for both  veGFs and Semaphorins. 
Nrps are involved in the control of the development of the 
neural, the lymphatic and the vascular systems and espe-
cially of axonal guidance (reviewed [55]). Nrps act merely 
as co-receptors and seem not to possess intrinsic catalytic 
activity [56]. Nrp-1 and -2 form complexes with veGFr-2 
and thereby fortify veGF-a-induced veGFr-2 activity 
[57–59]. Nrp-1 also binds with high affinity to veGFr-1, 
which counteracts an interaction of veGF-a and Nrp-1 and 
finally results in reduced veGF-a effectiveness [59]. this 
is yet another level of control of veGF-a dosage. Besides 
veGF-a isoforms, Nrp-1 binds to veGF-B, veGF-e, and 
PlGF, while Nrp-2 additionally has binding affinity for 
veGF-C and PlGF-2 (reviewed [10, 11, 36]). Phenotypic 
analysis of overexpression and knock-out mouse models 
of Nrps revealed that they are important regulators of the 
development of the vascular and the lymphatic systems as 
well as of the CNS [60–62].
the veGF family growth factors
veGF-a  has firstly been described as a vascular perme-
ability factor (vPF) in tumors and has been considered for 
a long time as an endothelial cell-specific mitogen [63]. Six 
Isoforms of veGF-a are generated by alternative splic-
ing, ranging in length from 121 to 206 amino acid residues 
(veGF121–206; reviewed [64]). the three major isoforms 
are veGF121, 165, and 189 in humans and veGF120, 
164, and 188 in mice. these isoforms differ in their bind-
ing affinity to extracellular matrix proteins and therefore 
show distinctions in their diffusion ability [65]. veGF-a 
is a mitogen for endothelial cells and a survival-promoting 
factor for newly formed vessels that is indispensible for 
the development of the vascular system [25]. In mice, even 
the deletion of only one allele of the Vegf-a gene  leads to 
embryonic lethality on day e9, due to a misbuilt vascular 
system of the whole embryo and the yolk sac [66–68]. In the 
embryo, gradients of veGF-a function as guidance cues for 
forming vessels [65, 69, 70]. likewise, these gradients are 
critical for brain development, as shown by raab et al. [71] 
in a mouse model of specific veGF deletion in neuroecto-
dermal cells. recently, lee et al. [72] showed an endothelial 
expression of veGF-a in the adult brain and revealed an 
autocrine effect on vascular homeostasis.
expression of veGF-a protein is regulated by many 
factors, among them hormones, growth factors, and oxy-
gen concentration. hypoxia-inducible factors (hIF1α and 
hIF2α) bind to a hypoxia response element (hre) in the 5′ 
Vegf-a promoter-region, thereby inducing veGF-a expres-
sion [73–75]. hence, veGF is upregulated and additionally 
promotes its trophic effects on endothelial and CNS cells 
following hypoxic conditions, e.g., during tissue growth 
in development or tumors [76,  77]. veGF-a synthesis 
is strongly upregulated after various pathological insults 
[78, 79]. Genetic mutation of the hre of the Vegf-a gene 
(veGFδ/δ mice) decreases veGF-a protein concentrations 
and leads to an adult-onset motor neurodegenerative phe-
notype, resembling alS [80]. thus, veGF-a is of great 
significance for therapeutic interventions in various patho-
logical settings.
veGF-B occurs in two isoforms and shows a great 
homology to veGF-a [81,  82]. like veGF-a, veGF-
B stimulates proliferation of endothelial cells in vitro and 
angiogenesis in vivo, although to a much lower extent than 
veGF-a and confined to certain conditions [81, 83]. In 
contrast to veGF-a, veGF-B is dispensable for embryonic 
vascular development. Mice bearing a homozygous dele-
tion of the Vegf-b gene (veGF-B−/−) are viable and fertile. 
Nonetheless, these animals exhibit disturbances in cardiac 
development and function [84, 85]. Moreover, animal mod-
els have shown a role for veGF-B in vascular remodeling 
under pathological conditions [86].
the promoter region of the Vegf-b gene lacks an hre 
and therefore, unlike veGF-a, the expression of veGF-B 
is not regulated by hypoxia [87]. though veGF-B is not 
essential for angiogenesis in most tissues and settings, it has 
been demonstrated to be a crucial survival factor for blood I. M. Wittko-Schneider et al.
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vessels [88, 89]. Due to the fact that veGF-B shows only 
minor angiogenic activity, veGF-B was shown to have a 
better safety profile as a neuroprotective survival molecule 
than veGF-a and might therefore be a good therapeutic tar-
get for neurodegenerative diseases [90].
PlGF has been discovered by its angiogenic role in the 
placental chorion and the maintenance and development 
of the human placenta [91]. three isoforms of PlGF exist 
in humans, but only one isoform (PlGF-2) has been found 
in mice [92]. Carmeliet et al. [93] showed that, whereas 
a genetic deletion of Plgf (PlGF−/−) in mice did not alter 
embryonic angiogenesis, it diminished vessel growth in 
pathological situations. In compliance with this, overex-
pression of Plgf increased angiogenesis and vessel perme-
ability [94]. Furthermore, genetic ablation of PlGF delays 
angiogenic reaction to hypoxia, and the accumulation of 
fibrinogen in microvessels of the brain [95], and thereby 
indirectly affects neuronal survival.
the phenotypes resulting from genetic deletion of all 
veGF family members and veGFrs in mice  have been 
nicely summarized and depicted in a review by Olsson et 
al. [37].
The neurobiology of VEGFR-1 and -2
although the role of veGF family members in neural cells 
has been studied extensively within the last decade and 
veGF-a has been demonstrated to be involved in many 
steps of nervous system development and function, the 
downstream signaling pathways and the roles of veGFrs 
are yet not fully understood. veGFs have been shown to 
affect NS/PCs differently in specific areas of the brain and 
at various stages of development. Great efforts have been 
made to explore and discriminate the direct and indirect 
neurotrophic effects of veGFs and to define the mediating 
receptors in neural cells. here, we portray and compare the 
physiological functions of veGFr-1 and -2 in the develop-
ing and the adult nervous system. table 1 summarizes the 
diverse functions of both veGFrs in neural cells. their 
functions are further illustrated in Fig. 1.
veGFr-1 and -2 are regulators of brain development
the development of the mammalian brain is based on the 
presence of undifferentiated, multi-potent NSCs that give 
rise to all neural cell types: (1) NPCs that can differentiate 
into all neuronal cell types of the brain and (2) glial precur-
sor cells, which generate astrocytes and oligodendrocytes. 
In the embryo, the first NSC populations are located in the 
ventricular zone (vZ), the multi-layered wall of the pri-
mordial ventricles that later gives rise to the subventricu-
lar zone (SvZ) and bears neurogenic potential throughout 
life. with the start of neurogenesis, multi-potent, self-
renewing radial glia develop from neuroepithelial cells 
situated in the wall of the neural tube. radial glia cells 
are present in great numbers at the peak of embryonic 
neurogenesis and serve as NSCs of the embryonic brain, 
but also function as migration scaffold for cortical precur-
sors. In the course of the development, the NSC number 
declines. later, a defined subgroup of radial glia trans-
forms  into a subpopulation of astrocytes, which serve as 
NSCs in postnatal and adult age (for detailed review, see 
[96–99]).
Expression of VEGFs and VEGFRs 1 and 2 in the 
developing brain
VEGF family ligands in the developing NS   In the embry-
onic brain, neuroectodermal cells of the vZ express high 
levels of veGF-a [100]. the resulting veGF-a-gradient 
from the vZ to the brain parenchyma most likely directs 
invading vessels/endothelial cells expressing veGFr-1 and 
-2 [100, 101]. homozygous deletion of Vegf-a in Nestin-
expressing (Nestin+) cells, i.e. primarily NS/PCs surround-
ing the lateral ventricles, results in disruption of angiogen-
esis and thereby reduces vascularization of the embryonic 
mouse brain [71,  102]. In addition, the loss of secreted 
veGF-a leads to extensive apoptosis of the cells surround-
ing the lateral ventricles. these transgenic mice display a 
phenotype that resembles human microencephaly, i.e. a 
severely reduced growth of the forebrain and a strong flat-
tening of the skull [71, 102].
after birth, neuronal expression of veGF under physi-
ological conditions has been described but is controver-
sial. Ogunshola et al. [32] showed neuronal veGF-a in 
early postnatal stages. later, postnatally, between P13 and 
P24, when angiogenic activity in the brain is highest, the 
expression of veGF-a changes to a primarily glial expres-
sion pattern. Glial expression of veGF-a has previously 
been linked to postnatal neurogenesis in the cerebellum 
[103]. Furthermore, veGF-a is expressed in Purkinje 
cells during postnatal development and is found in a radial 
concentration gradient from the Purkinje cell layer to the 
upper layers, corresponding to its chemoattractive function 
[19]. this points to an intertwining of brain angiogenesis 
and veGF expression in neurons and neuronal metabolism 
[32].
veGF-B mrNa is highly expressed in the murine embry-
onic CNS and spinal cord. lagercrantz et al. [104] reported 
even higher transcript levels of veGF-B than veGF-a in 
the developing mouse brain.
VEGFR-1 and -2 in the developing NS   Inconsistent results 
of veGFr-1 and -2 expression in the developing CNS Brain homeostasis
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have been published. During embryonic development, the 
mrNa of veGFr-1 and -2 veGFr-2 has been typically 
shown in brain endothelial cells of the murine brain, but it 
has also been detected in the embryonic forebrain (e15) on 
neural cells, which simultaneously express veGF-a. this 
is indicative of both  paracrine and autocrine effects of 
veGF-a in the developing brain [105]. In addition, expres-
sion of veGFr-2 and Nrp-1 has been demonstrated in 
subiculo-mamillary axons of the developing hippocampus 
[106]. Furthermore, in vitro, veGFr-1 and -2 expression 
Table 1   Comparison of the specific functions of veGFr-1 and -2 in neural cells under physiological conditions
Shows the functions of veGFrs in neural cells that have been proofed directly through loss-of-function experiments (normal black font) or 
strongly suggested (in italics, grey) by supporting dataI. M. Wittko-Schneider et al.
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has been shown in NS/NPCs [20]. Both  veGFr-1 and -2 
have been detected in cultured Nestin+ SvZ-derived NS/
PCs from newborn rats, which do not express markers of 
differentiated neurons, glial or endothelial cells [107]. In 
cortical explants of neonatal rats, veGFr-1 is expressed 
by astrocytes, where it mediates veGF-induced gliotrophic 
effects [108].
In the postnatal brain, a strongly regionalized expres-
sion of veGr-1 in neurons of the cortex, striatum, and 
hippocampus within the first weeks after birth has been 
described [109]. this neuronal expression decreases with 
age. at P30, only a few neurons reveal veGFr-1 immu-
noreactivity, whereas at P90, veGFr-1 expression is no 
longer detectable in neurons [109]. a similar switch of cell-
type-specific expression in early postnatal development has 
also been described for veGF-a (see above). In contrast 
to veGFr-1, according to Yang et al. [109], the number 
of mature neurons, which express veGFr-2, grows with 
age and expression is evenly distributed without regional 
differences.
Divergent roles of VEGFR-1 and -2 in developmental 
neurogenesis
until now, the role of veGFrs in embryonic CNS cells has 
not been entirely clarified. whereas a reduction of veGF-a 
results in strong defects in brain development mainly due 
to impaired vascularization, neither  the genetic deletion 
of veGFr-2 in Nestin+ cells and the deletion of veGFr-
1-signaling in mice show any severe developmental phe-
notype [49, 71, 102]. thus, veGFr-1 and -2 signaling in 
neural cells does not seem to be essential for CNS develop-
ment. Further studies dissecting indirect and direct effects 
of veGFs on neural cells and the involvement of veGFrs 
in vivo are difficult due to the early embryonic lethality of 
the knock-out mice [46, 53] and the concomitant changes 
in vascularization when modulating the veGF/veGFr 
system.
In vitro   Most studies unraveling veGFr signaling in 
cells of the developmental NS have used in vitro systems. 
although veGFr-2 is regarded as the main mediator of 
Fig. 1   veGFr-1 and -2 are expressed differently and exert diverse 
functions in distinct cell types of the nervous system under physio-
logical conditions. whereas veGFr-2 appears to be the main recep-
tor transmitting mitogenic effects in NPCs and differentiated neuronal 
cells, veGFr-1 seems to be the main receptor facilitating glial devel-
opment and survival. Both veGFrs mediate veGF-induced neuro-
protection and Müller glia cell survival in the adult retinaBrain homeostasis
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veGF-a-induced direct neurotrophic effects, effects of 
veGF-B, which only acts through veGFr-1 on NS/PCs, 
have also been reported. In embryonic cortical cultures, 
veGF-a and veGF-B dose-dependently increased prolif-
eration, whereas PlGF had no effect [21, 110, 111]. Jin 
et al. [110] reported that veGFr-2, but not veGFr-1, is 
expressed in these NS/PCs and that inhibitors of veGFr-2 
blocked the veGF-a-induced effect. From the same labo-
ratory, Sun et al. [21] showed that in this in vitro model 
veGF-B treatment increased newborn cells that express 
markers of early NS/PCs (here Nestin), but not of differ-
entiated neurons. unfortunately, no information about the 
veGFr expression was given in the latter publication. as 
veGF-B only binds to veGFr-1, but not -2, it is unclear 
how this effect is mediated. Both ligands, veGFa and 
veGFB, have binding affinities to Nrp co-receptors, but 
Nrps seem not capable of autonomous signal transduction 
and need  to form complexes with other rtKs [36, 56, 
112].
In primary cultures of cortical neurons derived from 
newborn rats (P1) veGFr-1 and -2 were expressed and, 
surprisingly, the expression of veGFr-2, but not -1, was 
amplified in response to the selective veGFr-1-ligand. 
PlGF acted neuroprotectively in these cultures in an in vitro 
model of cerebral ischemia, and this might secondarily be 
mediated by veGFr-2 [113]. Future studies using inhibi-
tors of veGFr-1 and -2 or genetic ablation of these rtKs 
are needed to unravel the intertwined neurotrophic signaling 
cascades of these receptors.
Besides the transduction of mitogenic signals of veGF-a, 
veGFr-2 mediated veGF-a-induced neuritic growth and 
maturation in an organotypic perinatal rat cortical explant 
model. In this process, the PI3-K/akt and the MaPK/
extracellular signal-regulated kinase (erK) pathways were 
activated downstream of veGFr-2. In primary neuronal 
cultures, veGF-a increased neuronal cell body size and 
stimulated neurite formation via veGFr-2 signaling [114]. 
In fetal and postnatal rat cortical organotypic explant cul-
tures, veGFr-1 has been shown to transduce veGF-a-
stimulated astrocytic proliferation. here, the MaPK/erK 
and PI-3 kinase signaling pathways were also identified as 
downstream signaling pathways. ectopic veGF enhanced 
expression of bFGF (basic fibroblast growth factor), which 
is a stimulating factor for NPCs [108]. this shows once 
more the potential interplay of the differentially expressed 
veGFr-1 and -2 in the regulation of neurogenesis.
also, in the developing PNS, veGF-a shows neurotrophic 
properties. In cultured murine superior cervical ganglia and 
DrG, veGF-a increased survival and neuritic outgrowth. the 
latter effect has been shown to be mediated by veGFr-2 [115].
In vivo  veGFr-2 has been demonstrated to employ a 
function in the development of the hippocampal axon tract, 
which plays an important role in memory and emotional 
behavior. Genetic deletion of veGFr-2 in Nestin+ cells 
altered embryonic development of the postcommissural for-
nix pathway and induced fiber loss of the postcommissural 
axons that project from the hippocampus to the hypothala-
mus. these changes, albeit less prominent, was not entirely 
compensated for during development and persist  at least 
into juvenile age (P30) [106]. In vitro, the veGFr-2 signal-
ing effect on axon growth occurred in response to Sema3a, 
but independent of veGF-a, by forming a receptor complex 
with Nrp-1 and PlexinD1, which activated the PI3 K/akt 
pathway [106]. a similar effect has been observed in Dros-
ophila, where genetic ablation of the PDGFr/veGFr 
homolog resulted in developmental defects of the com-
missural axons. these effects are preceded by survival and 
migration deficits in midline glial cells. here, the effect on 
midline glia was transmitted via the akt and erK pathways 
[116].
In summary, veGFr-1 and -2 transmit distinctive, non-
overlapping signals of veGF family members in prenatal/
perinatal neural cells. veGFr-2 seems to be the major 
receptor transmitting mitogenic and trophic signals in NS/
PCs and neurons as well as neurite growth and axon path-
finding cells, whereas veGFr-1 signaling mediates glial 
cell proliferation and survival. additional cell-type-specific 
and inducible knock-out animal models are needed to inves-
tigate the roles of veGFrs in nervous system development 
disconnected from the vasculature.
veGFr-1 and -2 exert distinct roles in adult neurogenesis
In the adult mammalian brain, physiological/spontaneous 
neurogenesis is mainly confined to two regions: the SvZ of 
the lateral ventricles and the dentate gyrus of the hippocam-
pus [117–120]. In the SvZ NSCs, which are GFaP-positive 
slow cycling cells, are located mainly in the lateral wall of 
the lateral ventricles [121, 122]. Most of the new olfactory 
neurons in the adult murine brain originate from there [120, 
123]. GFaP+ NSCs in the adult SvZ generate active, rapid 
transit amplifying cells (taPCs) typically found in clusters 
[122], which in turn produce NPCs that migrate through the 
rMS to the OB [120, 123, 124]. unlike the radially migrat-
ing neurons in the developing cerebral cortex [125], the 
adult SvZ-derived NPCs retain their proliferative activity 
and migrate in a chain migration mode [126] (Fig. 2).
NPC migration is tightly regulated. Glial cells secrete 
regulatory factors for neuronal guidance [127–129]. In the 
rMS, migrating NPCs are enwrapped by a glial tunnel con-
structed of specialized astrocytes and extracellular matrix 
proteins [130, 131]. On arrival in the olfactory bulb (OB), 
the NPCs detach from their chains and migrate as single cells 
radially towards their final position, where they differentiate I. M. Wittko-Schneider et al.
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into distinctive neuronal subtypes and functionally integrate 
into the existing network [132, 133] (Fig. 2). Most cells 
remain in the granular cell layer and adopt a GaBaergic 
phenotype, but few (5 %) migrate towards the outer layer, 
the periglomerular layer, where they differentiate into 
GaBaergic or dopaminergic interneurons [132–134]. until 
now, it has not been entirely clear if the NPCs are already 
primed to develop into a specific interneuron subtype in the 
SvZ or if determining signals define their latter phenotype 
during their migration through the rMS or even at their final 
location within the OB [135].
recent results suggest that NS/PCs itself may possess not 
only the potential to replace lost cells but may additionally 
have a beneficial effect on the surrounding tissue [136, 137]. 
Consequently, the mechanisms that control NS/PC behavior 
and the NSC state are of high therapeutic relevance.
Different expression patterns of VEGFR-1 and -2 in the 
adult rodent NS
VEGF family ligands in the adult rodent CNS   In the adult 
rodent, a low level of veGF expression has been observed 
throughout the entire brain, with the highest expression 
levels in the regions of canonical adult neurogenesis, in 
the plexus choroideus, and in the cerebellum [15, 19, 100, 
138–142]. From the choroid plexus, veGF-a is secreted 
into the liquor and can consequently act directly on ependy-
mal and subventricular cells that express veGFrs. Balenci 
[139] reported veGF-a expression in cells expressing the 
glial marker GFaP (glial fibrillary acidic protein; Fig. 3). 
Interestingly, glial cells of the SvZ and the rMS showed a 
specific elevated expression in comparison to glial cells of 
other regions [139]. veGF-a mrNa and veGF-a protein 
were furthermore detected in neurons, i.e. mitral cells and 
juxtaglomerular cells (periglomerular and tufted cells) as 
well as in astrocytes of the olfactory bulb (OB) [17]. Moreo-
ver, in the hippocampus, veGF-a is expressed in granule 
neurons and in proliferating cells that reside close to blood 
vessels, pointing to an direct mitogenic effect of veGF-a 
on NS/PCs [14]. Several studies have shown that veGF-a 
is expressed by cultured neural stem cells/neural progenitor 
cells (NS/PCs) from hippocampus, SvZ, and OB [15, 141, 
142].
In the adult cerebellum, veGF is expressed in Purkinje 
cells, Bergmann glia, and in astrocytes in the internal granu-
lar layer [19].
veGF-B is expressed in all vessels and the choroid plexus 
as well as in neurons of the adult rodent brain [143–145], and 
its expression is upregulated following brain injury [144].   
Fig. 2   Schema of olfactory neurogenesis. Subpopulations of GFaP+ 
cells serve as neural stem cells in the SvZ (NSC, blue). these gener-
ate transit-amplifying neural progenitor cells (taPC; green), which in 
turn produce neuronal progenitor cells (NPC; red). NPCs migrate in 
a chain migration mode along the RMS towards the Olfactory bulb. 
the rMS is ensheathed by glial cells (dark blue), which secrete reg-
ulatory factors, like veGF-a and BDNF (yellow) that influence the 
migration of the NPCs. Once arrived at the olfactory bulb, the NPCs 
detach from the chains and migrate individually, radially in the gran-
ular cell layer (GCL). a minority of cells migrate further outwards 
through the plexiform layer (PL) to the periglomerular cell layer 
(PGL)Brain homeostasis
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Fig. 3   expression of veGFr-1 and -2 and ligand veGF-a in the 
SvZ-rMS region of the adult brain. Immunostained sections from 
adult mouse brains show that, whereas veGFr-1 is expressed in 
GFaP+ cells of the SvZ and rMS (a sagittal section) we detected 
pveGFr-2 in DCX+ NPCs in these regions. the expression of 
pveGFr-2 was increased after intracerebroventricular injection of 
veGF-a protein (b coronal section; adapted with permission from 
Journal of Neuroscience from wittko et al. [16]; doi:10.1523/JNeu
rOSCI.5527-08.2009). the ligand veGF-a was found on SvZ and 
rMS glial cells and within the choroid plexus (c sagittal section). 
White arrows point to GFaP/veGF-a double-labeled cellsI. M. Wittko-Schneider et al.
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In rat midbrain cultures, veGF-B is expressed in all neurons, 
including dopaminergic neurons, and acts neuroprotectively 
in an in vitro model of Parkinson’s disease [146]. veGF-
B is further expressed by mouse motor neurons and dorsal 
root ganglion (DrG) neurons, and promotes motor neuron 
survival in an autocrine mode. astrocytes may upregulate 
veGF-B after injury to retain neuronal survival in a parac-
rine manner [147]. In addition, veGF-B mrNa was found 
to be highly expressed in the retina, where it also exerts a 
survival-promoting role [144]. Due to the fact that veGF-
B shows only minor angiogenic activity, veGF-B has been 
shown to have better safety profile as a neuroprotective sur-
vival molecule than veGF-a, [90] and might therefore be a 
good therapeutic target for neurodegenerative diseases.
whereas in adult mice PlGF is expressed in neurons, ves-
sels and astrocytes throughout the brain, and is upregulated 
after ischemic injury, it has not been detected in rat brains 
under physiological conditions [148]. In the peripheral 
nervous system (PNS), in sciatic nerves, and lumbar DrGs, 
PlGF is expressed in neuronal cells, but neither in myelating 
Schwann cells nor in endothelial cells [149].
VEGFR-1 and -2 in the adult rodent CNS   the veGFr-1 
and -2 are expressed in different patterns in regions of spon-
taneous adult neurogenesis. the endothelial expression 
of veGFr-1 and -2 seems to be related to the angiogenic 
activity in the tissue. under physiological conditions, there 
is practically no angiogenic activity in adult brain, and 
veGFr expression in brain endothelial cells is strongly 
reduced [109], but can be (re-)activated in response to injury 
[79, 148]. Nevertheless, a recent study reported veGFr-2 
and veGFr-1 mrNa in endothelial cells of the adult hip-
pocampus [18].
Many GFaP+ cells in the SvZ and the OB strongly 
express veGFr-1, as well as fewer cells in the hippocam-
pus (Fig. 3) [16]. In the adult SvZ, GFaP + cells have 
been reported as NSCs, which generate mainly neuroblasts 
[122]. however, the veGFr-1+/GFaP+ cells detected in 
the adult mouse brain were not proliferative themselves  but 
often located in ultimate proximity of vessels and prolifera-
tive DCX+ NPCs[16]. this suggests that veGFr-1 is part 
of the glia-vascular neurogenic niche, which influences NS/
PC development. endothelial cells and glial cells, especially 
astrocytes, secrete trophic factors, like veGF-a, FGF-2, 
bbrain-derived neurotrophic factor (BDNF) and others, that 
support the maintenance of the stem cell state, promote 
self-renewal of NCS and/or trigger neuronal determination, 
migration and differentiation (reviewed [127]). adult SvZ-
derived NPCs migrate through the rMS through a glial tun-
nel, which is built of specialized astrocytes and extracellular 
matrix components [130, 150]. veGFr-1 is expressed in 
the GFaP+ cells along the entire rMS and in the border-
ing corpus callosum of the adult mouse brain (Fig. 3) [16]. 
veGFr-1 is also expressed in activated astrocytes exposed 
to infused veGF-a in vivo [151]. In contrast, veGFr-2 is 
induced in neuronal and endothelial cells by infused veGF-
a or injury [151]. Furthermore, both veGFr-1 protein and 
mrNa have been shown in neurons in the pyramidal cell 
and the granule cell layer of adult rat hippocampus [152].
expression of veGFr-2 has been shown in ependymal 
cells of the lvs [15, 109] and in DCX+ NPCs of the hip-
pocampal subgranular zone and the SvZ of adult rats [20]. 
Phosphorylated (p)veGFr-2 was detected in DCX+ NPCs 
of the SvZ and rMS and is elevated after intracerebroven-
tricular infusion of veGF-a (Fig. 3). levels of pveGFr-2 
are similarly boosted in veGFr-1tK−/− mice, which 
exhibit higher concentrations of veGF-a protein in their 
brain tissue. Intriguingly, pveGFr-2 has not been found in 
the OB in these conditions/animals [16]. thus, veGFr-2+ 
NPCs seem to lose their phosphorylated state when entering 
the OB [16].
Furthermore, migrating cerebellar granular cells express 
veGFr-2, which mediates veGF-a-induced chemoattrac-
tion [19].
VEGFR-1 and -2 in adult rodent CNS cells in vitro   the 
regional and cellular heterogeneity of veGF receptor 
expression in areas of spontaneous adult neurogenesis 
implies distinct functions of both receptors in the regula-
tion of adult neurogenesis and CNS maintenance. veG-
Frs may contribute to the region specific properties and 
cell fate of adult CNS stem cells. this is supported by 
the diverse expression pattern of veGF receptors that has 
been demonstrated in cultured adult NSCs derived from 
different origins (SvZ, OB, hippocampus) and which 
changes in response to veGF-a [15, 142]. In vitro data 
of veGFr expression differ greatly between studies ana-
lyzing different brain regions, time-points of development 
or animals and also between laboratories. expression of 
veGFr-2 and veGF-a protein, but not vegfr-1 mrNa, 
have been shown in NS/PCs isolated from juvenile rat 
SvZ [142], whereas mrNas of veGF-a, veGFr-1 and 
veGFr2 mrNa were detected in adult mice SvZ-derived 
NS/PCs [141]. Supplementary, veGFr-1 and -2 protein 
were revealed in cultured NS/PCs generated from the SvZ 
of newborn rats [107].
VEGFR-1 and -2 in the adult rodent PNS   veGFrs 1 
and 2 are not only expressed in neural cells of the brain. 
Poesen et al. [147] demonstrated veGFr-1 expression also 
in spinal motor neurons and astrocytes of wildtype and pre-
symptomatic adult mice overexpressing a mutated human 
superoxide dismutase-1 gene, which serves as a mouse 
model for alS. Furthermore, primary embryonic motor 
neurons and astrocytes, express veGFr-1 and veGF-B, 
implying an autocrine neurotrophic effect [147]. likewise, Brain homeostasis
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veGFr-1 and -2 are constitutively expressed in neurons, 
vascular endothelial cells and some astrocytes of the spi-
nal cord [153]. Besides this, veGFr-2 expression has been 
found in cultured superior cervical ganglia and DrGs of 
adult mice [13].
VEGFR-1 and -2 in the adult primate brain   In contrast to 
the expression pattern in the adult rodent brain, veGFr-1 is 
expressed in proliferating cells and in Nestin+ cells of the 
SvZ of the adult primate brain. In this context, veGFr-2 
is mainly detectable in the vessel walls, predominantly in 
endothelial cells. astonishingly, veGFr-1 has not been 
detected in the primate rMS [154]. Possibly the glial tunnel 
and so also veGFr-1 signaling is not of comparable impor-
tance in the primate brain, due to the brain anatomy and to 
the facts that migration distances are relatively much shorter 
than in the rodent and that olfactory neurogenesis is of much 
lower significance in primates and humans.
Generation of new neural cells from adult NPCs in vitro
Cultured NS/PCs isolated from the regions of adult spon-
taneous neurogenesis express veGF-a and stimulate adult   
NS/PC proliferation dose-dependently in an autocrine manner  
via veGFr-2. effective doses vary widely between studies. 
Schänzer et al. demonstrated a maximal stimulation at 50 ng/ml  
veGF-a [15]. In contrast, Meng et al. [141] reported that 
low doses of veGF-a (here, 50 ng/ml) upregulated the 
expression of veGFr-1 and -2 in adult SvZ-derived neuro-
sphere cultures, but did not alter cell proliferation or differen-
tiation, whereas very high amounts of veGF-a (500 ng/ml)   
induced a decline of veGFr expression accompanied by an 
amplified proliferation of NS/PCs and neuronal differentia-
tion. Furthermore, high doses of veGF-a expanded GFaP+ 
cells [141]. unfortunately, it has not been shown if veGFr-1 
is directly involved in GFaP+ cell proliferation or survival 
in these experiments. the fact that high doses of veGFa 
reduce veGFr expression, but simultaneously induce neu-
rotrophic effects, let Meng et al. [141] hypothesize that 
another receptor, i.e. Nrp that interacts with veGFrs and 
modulates veGF-a signals in NS/PCs, may be responsible 
for the signal transduction in these cells. an autocrine effect 
of veGF-a on NS/PCs in vitro has been demonstrated by 
blocking of veGFr-2 with an specific inhibitor [15].
So far, no direct influence of PlGF on the adult CNS 
under physiological conditions has been reported. however, 
PlGF has been shown to act neuroprotectively on astrocytes 
and neurons in vitro [95].
Generation of new neurons in the adult NS in vivo
although considerable efforts have been spent analyzing 
downstream pathways and identifying direct and indirect 
neurotrophic effects of veGFs on adult neural cells, it has 
been very difficult to define the mediating receptor in vivo 
and to exclude secondary effects, due to the vast number of 
cell types that respond to veGF family members.
VEGFR-1 and -2 control proliferation, differentiation and 
survival of SVZ-derived NS/PCs   In vivo, the intracer-
ebroventricular infusion of veGF-a with osmotic mini-
pumps into adult rats at a low dose (2.4 ng/day) increased 
the quantity of neurospheres generated from the lateral 
ventricle wall and the number of new neurons in the OB 
and the hippocampus. this boost in neurogenesis neither 
resulted from an enhanced proliferative activity of NS/PCs 
in esponse to veGF-a nor was it accompanied by changes 
in the vasculature, but was due to improved survival of NS/
PCs [15]. In contrast, another study reported a prolifera-
tion-promoting effect of ectopic veGF-a, but no decrease 
in apoptosis [20]. In the latter study, a higher dose of veGF 
has been used and vascular effects have been observed. 
Similar to the in vitro situation, effects of veGF-a on adult 
neurogenesis seem to be dose-dependent in vivo. unlike 
in cultured cells, in vivo the involvement of veGFr-2 
in veGF-a induced adult neurogenesis has not yet been 
clearly shown.
recently, we could show for the first time that endogenous 
veGF-a stimulates neurogenesis in the adult mouse brain. 
Proliferation of DCX+ NPCs was amplified in the SvZ, but 
not in the rMS of veGFr-1-signaling-deficient mice that 
exhibit elevated veGF-a protein levels [16]. Contrastingly, 
the number of non-neuronal cells in neurogenic regions was 
not increased by infused veGF-a in the rat [15]. this was 
supported by our study, which showed that elevated levels 
of veGF-a in veGFr-1tK−/− mice neither alter the prolif-
erative activity of GFaP+ cells nor augment the generation 
of mature GFaP+ cells in the SvZ/rMS/OB. at the same 
time, proliferative DCX−/GFaP− cells have been signifi-
cantly reduced. the elevated levels of endogenous veGF-a 
in these mice seem to selectively activate NPC proliferation 
in the adult SvZ. In line with this, veGFr-1tK−/− mice and 
mice that received ectopic veGF-a intracerebroventricu-
lary displayed an elevated phosphorylation of veGFr-2 in 
migrating DCX+ NPCs, indicating that veGF-a directly 
augments NPCs migration and proliferation via veGFr-2 
[16]. Infusion of a specific veGFr-2 inhibitor into the adult 
brain could elucidate the underlying signaling cascade in 
detail in vivo.
the increase of newly formed NPCs in the SvZ of 
veGFr-1tK−/− mice lead to more mature neurons in the 
OB, especially in the outer cell layers, the periglomerular 
layer, and the plexiform layer [16]. Conversely, the inhibi-
tion of veGF-a in adult mice did not alter the number of 
neurons in the OB, but affected dendritogenesis of newly 
formed neurons in the periglomerular layer [17]. this I. M. Wittko-Schneider et al.
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implies that veGF-a is not essential for, but stimulates, 
adult olfactory neurogenesis in the adult OB [17].
In contrast to the observed specific stimulation of neu-
ronal development after the intracerebroventricular delivery 
of veGF-a [15, 16, 20], infusion of veGF-a into the adult 
rat striatum strongly induced astroglial proliferation. here, 
veGFr-1, but not -2, was expressed in activated astrocytes 
[151].
veGF-B that only binds veGFr-1 and NrP-1  has also 
been identified as a neurotrophic factor that triggers NS/
PCs proliferation in the SvZ and the hippocampus [21]. In 
compliance with this, veGF-B−/− mice display a reduced 
neurogenic activity in the adult brain. Intracerebral infu-
sion of veGF-B compensated for this effect and increased 
neurogenesis up to physiological level [21]. the absence 
of veGFr-1 in NS/PCs in the rodent adult brain argues 
against a direct neurotrophic effect of veGF-B in vivo. as 
veGFr-1 is expressed on GFaP+ cells in regions of olfac-
tory neurogenesis, these cells might transmit a mitogenic 
factor for NS/PCs in response to veGF-B [16]. Further-
more, in vivo studies are needed to unravel the individual 
specific functions of veGFr-1 and -2 in neural cell types.
VEGFR-1 and -2 regulate hippocampal neurogenesis and 
function  In the hippocampus, veGF-a is coupled not 
only with neurogenesis but also with learning and memory. 
veGF-a expression is upregulated during intensive memory 
tasks and in an enriched environment [155]. In turn, overex-
pression of veGF-a in hippocampal neurons triggers neu-
rogenesis and angiogenesis and leads to an improvement of 
cognitive capabilities. In line with this, the molecular inhi-
bition of veGF-a expression abolishes the environmental-
induced boost of neurogenesis [155]. the positive effect of 
veGF-a on hippocampal neurogenesis is likely mediated 
by veGFr-2, as neural expression of a dominant-negative 
veGFr-2 in the hippocampus reduces proliferative activity 
and learning ability. the hypothesis of a direct effect via 
neural-expressed veGFr-2 is further supported by the fact 
that co-expression of a mutant form of veGFr-2 antago-
nized veGF-enhanced neurogenesis and learning without 
an affect on endothelial cell proliferation [155].
a recent study from licht et al. [18] reported a regu-
latory function of veGF-a in neuronal plasticity in the 
adult hippocampus. Inducible neuronal veGF-a overex-
pression in a transgenic mouse model resulted in increased 
hippocampal angiogenesis, enhanced neurogenesis, and 
improved hippocampal-dependent contextual memory. In 
accordance with this, the loss of veGF-a impaired mem-
ory without detectable effects on vascularization or neu-
rogenesis. Furthermore, veGF-a modulated long-term 
potentiation (ltP) in dentate gyrus granule cells [18]. It has 
yet not been clarified  which receptor mediates this effect. 
In these mice, veGFr-1 and -2 have not been detected on 
neuronal cells in wild-type or in reporter-mice, but Nrp-1 
and -2 have been [18]. however, Nrps seem not to be able 
to transduce veGF-a signals independently, due to their 
short intracellular domain lacking catalytic activity [10]. 
unfortunately, the expression pattern of veGFrs has not 
been examined in the veGF overexpressing mouse model 
in this study.
In contrast to veGF-a, the overexpression of PlGF, 
which selectively binds to veGFr-1, but not -2, blocks 
learning capability and reduces neurogenesis [155]. this 
suggests that veGFr-1 is a negative regulator of hippocam-
pal neurogenesis similar to its role in rMS migration or 
endothelial proliferation.
veGF-B, which also binds only to veGFr-1 and Nrp-1, 
but not veGFr-2, promotes proliferation of NPCs in the 
hippocampus [21] and points to a positive regulation via 
veGFr-1.
Further studies are necessary in order to unravel the exact 
mechanism of hippocampal neurogenesis and learning and 
memory and the involvement of veGFrs in a regulatory 
function.
Neuronal specification of specific subtypes: dopaminergic 
neurons
Besides its general role in the main regions of physiological 
adult neurogenesis, veGF seems also to have a role in the 
development and maintenance of specific neuronal subtypes, 
specifically dopaminergic neurons. this hypothesis is sup-
ported by an earlier study from Silverman et al. [156], which 
demonstrates that veGF-a stimulates the development of 
dopaminergic neurons in vitro in mesencephalic explants from 
prenatal rats. likewise, the administration of veGF-a to cul-
tures of forming embryoid bodies from human embryonic stem 
cells notably fosters the production of neuroectodermal cells, 
which mostly differentiate into neurons that seem to retain the 
dopaminergic phenotype [157]. In cultures of fetal ventral mes-
encephalic cells, veGF-a improved dopaminergic cell sur-
vival and increased neurite length [158]. In vivo data provide 
additional support for this idea. Neuron-specific inactivation of 
hIF-1α in mice leads to a reduction of dopaminergic neurons 
of the substantia nigra in the mutant compared to wild-type 
mice. this result has been ascribed to lower levels of veGF-a 
protein in the brain tissue of these mice. Interestingly, dopa-
minergic cells in the ventral tegmental area remained unaf-
fected [159]. until now, it has not been elucidated whether the 
decrease in dopaminergic neurons is an adult-onset effect or 
whether veGF-a influences the development of the dopamin-
ergic system in vivo. Furthermore, the signaling pathway that 
is underlying this effect has not been shown. however, expres-
sion levels of veGFr-1 and -2 in mice were significantly 
higher in mesencephalic NPCs compared with frontal NPCs. 
In hIF-1α-deficient mice, veGFr-2 expression was increased Brain homeostasis
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in NPCs compared with controls [159]. veGFr-1 has addi-
tionally been detected on mesencephalic astrocytes. Silverman 
et al. [156] showed that veGF binding sites were densest on 
blood vessels and astroglial cells. Based on these findings, 
the authors hypothesized that neurogenic effects of veGF on 
dopaminergic neurons in the mesencephalic explants are sec-
ondary effects of other trophic factors [156]. Glial cells that 
directly respond to veGF are likely to secrete these survival- 
and proliferation-stimulating factors. veGFr-1 is expressed in 
astroglial cells of the brain [16, 108] and might be a mediator 
of these veGF-induced neurotrophic effects.
In contradiction, Studer et al. [160] reported that adminis-
tration of veGF-a recombinant protein or veGF neutralizing  
antibody did not affect the generation of dopaminergic neu-
rons in embryonic (e12) rat mesencephalon cell cultures 
under lowered oxygen or 20 % oxygen condition, although 
veGF-a has been upregulated in lower oxygen condition 
in these cultures. No GFaP+ cells were detected in these 
mesencephalic cell cultures [160]. this could support the 
theory of a glial cell-mediated indirect neurotrophic effect 
of veGF-a.
however, adult veGFr-1tK−/− mice, which show an 
increased amount of veGF-a in the brain, have higher 
numbers of dopaminergic olfactory neurons in the periglo-
merular layer than control animals [16]. until now, it is not 
clear if the different interneuron subtypes arise from one 
multi-potent precursor cell in the SvZ and if the final cell 
fate of the NPCs is (1) already determined prior to their 
migration through the rMS or (2) becomes specified dur-
ing rMS migration, or (3) even not until their integra-
tion within the OB [135, 161–164]. Yet, in the rMS of 
the veGFr-1tK−/− mice, increased phosphorylation of 
veGFr-2 on migrating NPCs has been detected, so there a 
direct effect of veGF-a on the migrating NPCs, while an 
indirect effect on later fate determination within the OB is 
conceivable [16].
Besides veGF-a signals, veGFr-2 might likewise 
transmit neuroprotective signals of veGF-C in primary 
e13.5 dopaminergic neurons. rNa of vegfr-1 and -2 as 
well as nrp1 and nrp2 were abundantly expressed in embry-
onic midbrain cultures, but levels of vegfr-3 rNa were very 
low. however, transcription of Vegfr-1 and -3 increased after 
veGF-C treatment, suggesting an effect of veGF-C medi-
ated by veGFr-2 and/or veGFr-3 [165].
In pathophysiological in vivo models of Parkinson’s dis-
ease, neuroprotective effects of veGF-a and -B have been 
published [165–167]. Furthermore, veGF-a is upregulated 
in the substantia nigra but not in the striatum of Parkinson’s 
disease  patients [168]. this, together with the known pos-
sible vascular side effects, demonstrates the importance of 
elucidating the exact mechanism of neurotrophic proper-
ties of veGF with regard to the development of therapeutic 
interventions.
effects of veGFrs on neural cell migration in the 
developing and adult NS
VEGFRs trigger the migration of CNS cells
the motility of NSCs and their ability to migrate to a region 
of insult or growth is an essential property for the develop-
ment, maintenance, and repair of the nervous system, and 
emphasizes their importance as therapeutic targets for neu-
rodegenerative diseases or nervous system injury. veGFrs 
mediate indirect and direct effects on neural migration and 
chemoattraction in the adult CNS and during development.
Multiple studies have shown a direct effect of veGFs 
via veGFrs in neural cell culture models. For example, 
veGFr-2, but not veGFr-1, facilitates veGF-a-induced 
migration and chemoattraction of FGF-2-stimulated sub-
ventricular NS/PCs in vitro [107]. In a neurosphere model 
derived from neonatal SvZ, blockade of veGF and inhi-
bition of veGFr-1-signaling by neutralizing antibodies 
resulted in a modified morphology of GFaP + cells and 
interfered with sphere formation and migration. Inhibition 
of veGFr-2 decreased the migration capacity of these 
GFaP+ cells to a lesser extent, and concomitantly led to a 
reduction of veGF-a expression [169].
One of the first studies showing an indirect effect of 
veGF on neuronal migration in vivo is from loissant et al. 
[12]. the authors demonstrated an indirect effect of veGF-
a on neuronal migration via veGFr-2+ endothelial cells 
in the higher vocal center of adult canaries. a testosterone-
secreting implant induced an increase in angiogenic activity 
and expression of veGF-a in this brain region. veGFr-
2-expressing endothelial cells in turn produced the neu-
rotrophic factor BDNF in response to veGF-a. this was 
preceded by the recruitment of new neuronal cells into the 
higher vocal center of the neostriatum. veGFr-2 inhibitor 
in vivo and in vitro blocked this mechanism [12].
we recently showed for the first time a physiologi-
cal role for veGFr-1 signaling and endogenous veGF-
a on the migration of veGFr-2-expressing NPCs in the 
adult rMS in vivo [16]. In adult mice, we demonstrated 
that veGFr-1 signaling negatively regulates NPC migra-
tion. veGFr-1 is expressed in GFaP+ cells of the glial 
tube through which NPCs migrate on their way to the OB. 
Genetic inhibition of veGFr-1 signaling in mice increased 
veGF-a protein levels in the brain tissue, which resulted 
in an increased phosphorylation of veGFr-2 in migrating 
NPCs. this effect was mimicked by intracerebroventricular 
infusion of veGF-a. the enhanced migration towards the 
OB leads to an increased volume of the structure. In accord-
ance with these findings, NS/PCs of SvZ-derived explants 
of these mice exhibited an enhanced migratory speed [16]. 
these data strongly suggest that interplay of veGFrs 
expressed in different cell types regulate rMS migration, I. M. Wittko-Schneider et al.
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whereby astroglial veGFr-1 most likely indirectly con-
trols veGFr-2 activity in NPCs via alternation of veGF-a 
concentrations.
the vasculature has been shown to serve as a migration 
substrate for NPCs on their way to the OB. the sheathing 
endothelial cells and astrocytes of the rMS secrete signal-
ing molecules that are crucial for the control of NPC migra-
tion [170, 171]. Bozoyan et al. [170] showed that astrocytic 
veGF-a directs blood vessel development of the rMS and 
thereby affects neuroblasts migration during early postna-
tal development in vivo. here, veGF-a downregulation by 
mirNa in astrocytes in postnatal mice (P3-4) altered the 
development of the blood vessel scaffold in the rMS and 
reduced neuroblasts migration (P15-17) to the olfactory 
bulb. licht et al. [17] demonstrated that sequestering of 
veGF leads to collapse of the embryonic rMS vasculature 
and eliminates premature rMS migration. whereas SvZ-
derived neuroblasts of adult veGFr-1-signaling-deficient 
mice, which exhibit elevated veGF-a protein levels in vivo, 
migrate faster in explant culture [16], the addition of veGF-
a to postnatal slice cultures (P12–17) or the downregula-
tion of veGF-a in astrocytes did not alter neuroblast migra-
tion. this points towards a vasculature-dependent effect of 
veGF-a in postnatal development [170]. taken together, 
these findings suggest that veGF-a is essential for embry-
onic, and strongly beneficial for adult, rMS migration.
the veGF-a enhances neuroblast migration most likely 
through a direct mechanism via binding to veGFr-2 
in NPCs in the adult brain [16], but not during postnatal 
development [170]. veGF-expression levels vary in astro-
cytes of the SvZ and rMS during postnatal development 
[170]. Consequently, different mechanisms of veGF-a 
actions in the distinct developmental stages are conceivable. 
Snapyan et al. [171] have demonstrated that endothelial 
BDNF directly stimulates NPC migration. therefore, it is 
conceivable that astrocytic veGF-a acts directly on migrat-
ing NPCs via veGFr-2, but also indirectly by stimulating 
endothelial cells to produce BDNF, which in turn addition-
ally fosters NPC migration. here again, in vivo blockade 
of veGFr-2 in NPCs could probably answer the question 
if veGF-a directly or indirectly controls rMS neuroblast 
migration.
veGF additionally functions as a chemoattractive guid-
ance molecule for cerebellar granule cells. these cells 
migrate from the external granule cell layer toward the 
Purkinje cell layer. Cerebellar granule cells express the 
veGFr-2 and are guided by a veGF-a gradient depend-
ent on matrix-binding isoforms. Data from cerebellar 
slice cultures and in vivo experiments strongly suggest 
that veGFr-2 mediates veGF-a-guided granule cell 
migration [19]. the transmission of this effect is based 
on an interaction of veGFr-2 and NMDars. NMDars 
are also expressed by migrating granule cells and control 
their migration. veGFr-2 modifies NMDar function and 
enhances the conductance and [Ca2+] influx of NMDar in 
postnatal granule cell neurons prior to synaptogenesis, at a 
time when excitatory glutamatergic synaptic inputs on GCs 
have not yet been established [172]. a recent study from 
liu et al. [173] compared chemotactic responses of NS/PCs 
to veGF-a and downstream signaling pathways, using a 
murine NSC line C17.2 derived from the external germinal 
layer of the postnatal cerebellum. In these cells, chemoat-
traction towards veGF-a changes and is dependent on the 
differentiation status of the cells.
Besides their role in NPC migration veGFrs are reg-
ulators of neuronal patterning in conjunction with Nrp-
receptors. veGFr-1 has been shown to interact with 
Nrp-1 in a medulloblastoma-derived NPC line transmitting 
veGF-a signals fostering migration, survival, and prolif-
eration. veGF165 competitively inhibited Sema3a-induced 
cell migration and apoptosis by binding to Nrp-1, thereby 
blocking the formation of a signaling complex of NrP1 and 
veGFr1 [174].
Moreover, veGF-a has been shown to guide axon path-
finding of rGCs at the optic chiasm during development. 
here, veGF-a is expressed at the midline of the optic chi-
asm and acts via NrP1 in contralaterally projecting rGCs 
[175].
likewise, the effects on neurons and astrocytes veG-
Frs mediate migration of oligodendrocyte precursor cells 
(OPCs). recently, hayakawa et al. [176] reported a migra-
tion-promoting effect of veGF-a on rat OPCs in vitro that 
is mediated via veGFr-2. unlike veGF-C, which acts 
mitogenically on OPCs through veGFr-3, veGF-a did not 
affect OPC proliferation or differentiation [22, 176]. Fur-
thermore, conditioned medium of cerebral endothelial cells 
increased OPC proliferation and migration, but only migra-
tion was blocked when veGFr-2 signaling was inhibited, 
suggesting that migration and proliferation are regulated 
through different pathways involving different veGF fam-
ily members and veGFrs [176].
VEGFRs influence the migration of PNS cells
In the PNS, interplay of Sema3a and veGF-a regulates the 
migration of cells, cell somata of motor neurons, and axonal 
growth and pathfinding.
veGFr-1, but not veGFr-2, is expressed in motor 
neurons of the facial nerve, leading to the assumption that 
veGF-a induces the formation of a complex of veGFr-1 
and Nrp-1 that then transmits the veGF-a signal [177]. 
Furthermore, veGF-a and Nrps-1 co-operate on the con-
trol of migration of neural crest cells invading the branchial 
arch during development in chick embryos. veGFr-2 is 
also expressed in these cells and therefore likely to medi-
ate veGF-a signals through interaction with Nrp-1. Similar Brain homeostasis
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to the regulation of migration in motor neurons, the ligand 
Sema3a acts as a chemorepellent in neural crest cells [178]. 
thus, the expression of veGFrs together with their co-
receptors for complex formation is another level of control 
in neuronal development.
veGFrs and Nrps have also been shown to play an 
important role in axon growth at sympathetic neurovascu-
lar junctions that are critically involved in the determina-
tion of blood pressure and blood flow. at the neurovascular 
junctions in neonatal and adult rats, veGF-a is expressed 
in vascular smooth muscle cells and cells of the arteries, 
whereas veGF receptors NrP-1, veGFr-1, and veGFr-2 
are expressed in postganglionic sympathetic neurons. 
veGF-a blocks Sema3a-induced growth cone collapse in 
vitro, probably via NrP-1, and induces growth cone spread-
ing through veGFr-1 signaling. In vivo, the neutralization 
of veGF hindered the re-innervation of denervated femoral 
arteries, implying that veGF stimulates axons re-growth 
and/or directed the growth of axons to the denervated vessel 
[179].
Similarly, PlGF has been reported to influence PNS cell 
migration. PlGF is expressed in neuronal cells in sciatic 
nerves and lumbar DrGs, but not in myelating Schwann 
cells or in endothelial cells [149]. In peripheral neurons, 
PlGF-2 has been shown to have anti-chemorepulsive 
properties and to stimulate growth cone formation [180]. 
Nrp-1 has been suggested to transduce PlGF-2 chemoat-
traction, but the signaling co-receptor has not yet been 
identified.
Further experiments are needed to clarify the role of 
veGFrs in PNS cell migration and axonal growth and 
pathfinding.
roles of veGFrs in retinal development, maintenance and 
function
the vertebrate retina is a part of the CNS that is derived 
from the optic cup, which emerges from the neural tube at 
the region of the ventral diencephalon before the onset of 
neurogenesis. Cells from the luminar side of the optic cup 
form a vZ and show high mitogenic activity during devel-
opment. retinal progenitor cells (rPCs) are located near the 
ventricular surface, whereas postmitotic cells migrate to their 
site of differentiation thus forming the laminar structure of 
the retina [181]. the majority of retinal cell types (cones, gan-
glion cells, horizontal cells) develop prior to birth, but differ-
entiation of the rods occurs postnatally [182] (for reviews, see 
[183, 184]). Interestingly, the vertebrate peripheral retina is 
still avascular at birth, and in mice vascularization takes place 
within the first 2 weeks of life. therefore, the effects of veGF 
on neural cells can be studied in this part of the murine retina 
during this time frame excluding vascular interactions [185].
VEGFR-1 and -2 in retinal embryonic development
During development, transcripts of Vegfr-1 and -2 are 
expressed in rPCs. expression of veGFr-2 mrNa in 
rPCs occurs throughout neuronal differentiation, but 
veGFr-2 mrNa and protein levels in the retina fluctuate 
during development. Simultaneously, veGF-a is expressed 
adjacent to the veGFr-2 + cells, pointing towards a direct 
effect of veGF-a in retina development [181]. In retinal 
pigment epithelial cells (rPes), veGF expression has been 
detected in the optic vesicle at e9.5, whereas veGFr-2 was 
detected the earliest at P6.5 and increasing gradually until 
full expression was reached at P8.5 [186]. In vitro, veGF 
increases the number of photoreceptor cells and rhodopsin 
protein levels. the mitogenic response to veGF increases 
during development from e15 to P1 [182]. Furthermore, 
neutralization of veGF-a increases apoptosis and lowers 
microvilli density and size [186].
Postnatal veGFr-1 and -2 mrNa and protein have also 
been detected in non-vascular cells of the retina [182]. Saint-
Geniez et al. [187] described astrocytes in the retinal gan-
glion cell (rGC) layer, the cells of inner nuclear layer, and 
Müller glial cells as veGF-a-expressing cells. later, during 
postnatal development (P17–33), the expression was associ-
ated with retinal vessels. the expression of veGFrs begins 
in the superficial layer and proceeds to the deeper layers, 
followed by vascularization of the tissue region. Inhibition 
of veGFrs during early postnatal retinal development on 
the peripheral, at that time avascular, retina induced a loss of 
cells in the inner nuclear layer where Müller cells reside and 
in the ganglion layer, in which astrocytes are also located. 
the mitogenic effect of veGF-a might be further medi-
ated by MaPK as a downstream target of veGFrs [185]. 
In addition, Nishiguchi et al. [188] reported that veGFr-2 
is expressed in proliferating cells of the postnatal murine 
retina and that veGF-a triggers the proliferation of rPCs 
through veGFr2/Flk1 in explant cultures.
In accordance with these results in rodents, veGFr-2 
has been detected in rPCs in the vZ of the early postnatal 
chick retina, which develops completely avascular. veGF-
a is expressed by postmitotic neurons. Gain- and loss-of-
function experiments revealed a proliferative response to 
veGF-a that is mediated via veGFr-2 in vitro and in vivo. 
while inducing rPC proliferation, veGF-a suppresses the 
differentiation of cells. Knock-down experiments showed 
that veGFr-2 is the mediator of both effects. although 
veGF-a acts through the same receptor, the downstream 
signaling pathways in both cell types are divergent. veGF-
induced proliferation of rPCs was dependent on MeK–
erK activation, whereas the inhibitory effect on rGC 
differentiation was independent of this pathway. Interest-
ingly, amacrine cell differentiation at the same time was I. M. Wittko-Schneider et al.
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not affected, suggesting cell-type-specific responsiveness to 
veGF-a signals [189].
Neurotrophic effects of VEGFR-1 and -2 in the adult retina
In vivo, veGF-a is expressed by rPes as well as by retinal 
neurons and glial cells [190, 191]. veGFr-2 and veGFr-1 
expression was detected in adult photoreceptor and Mül-
ler glia and vascular cells [187]. veGFr-2 has also been 
detected in rGCs of the adult retina [192, 193]. Müller cells 
additionally express Nrp-1. the expression of three recep-
tors for veGF in Müller glia points to an autocrine effect of 
veGFs in vivo that has been demonstrated in a Müller glia 
cell line [187].
Conflicting results exist concerning the effect of veGFs 
on adult retinal cell survival. two studies have shown that 
in vivo inhibition of veGF signaling or sequestering of 
veGFs, similar to the treatment of degenerative eye diseases 
due to vascular overgrowth, does not change photoreceptor 
or ganglionic cell viability or alter retinal function in adult 
and juvenile mice [190, 191]. In contrast, Saint-Geniez et al. 
[187] reported that systemic veGF neutralization in adult 
mice via an adenovirus expressing sveGFr-1 did not alter 
the retinal vascularization, but induced massive cell death in 
Müller cells, and amacrine and photoreceptor cells, which 
led to visual dysfunction. From the same laboratory, Ford 
et al. [186] reported degenerative changes of rPes in the 
same mouse model after systemic veGF-a neutralization. 
In photoreceptors, veGF-a acted neuroprotectively against 
cell death induced by serum starvation. veGFr-2 is con-
stantly active in the adult retina, which points to a role in ret-
inal homeostasis. In accordance with this, systemic block-
ade of veGF for 8 weeks in mice caused loss of rGC [187].
under pathophysiological conditions, veGFr-2, but not 
veGFr-1, signaling has been suggested to mediate retinal 
neuroprotection during ischemic injury [194]. this is sup-
ported by a study of Böcker-Meffert et al. [195], which 
demonstrates that veGFr-2 mediates veGF-a-stimulated 
neurite regrowth of axotomized rGCs in retinal explant cul-
tures of postnatal rats (P11). In contrast, li et al. [144] dem-
onstrated expression and function of veGFr-1 in retinal 
neuroprotection in a pathophysiological model. Blockade of 
veGFr-1 eliminates the inhibitory effect of veGF-B on the 
expression of anti-apoptotic genes in rGCs, strongly sug-
gesting that veGFr-1 mediates the neuroprotective proper-
ties of veGF-B in the retina. In contradiction to veGF-a, 
veGF-B lacks a general angiogenic activity (except in the 
heart), which makes it an ideal candidate for neuroprotec-
tive therapies without affecting the vascular system [89].
In summary, the different veGF family members and 
veGFrs exert distinct functions in the retina. whereas 
veGFr-2 appears to be the main receptor facilitating mito-
genic effects of veGF-a during retinal development, both 
veGFrs mediate veGF-induced neuroprotection in the 
adult retina.
Conclusions and outlook
the veGF/veGFr signaling system, initially discovered 
in the vascular system and thought to act specifically in the 
vascular system, clearly plays an important role in neural 
development, neural homeostasis, and recovery after neu-
ronal injury. the findings that veGF-a has a direct effect 
on neural progenitors as well as on differentiated neuronal 
cells, and may promote neurogenesis, neural migration, 
neuronal survival, and differentiation, has paved the way for 
novel therapeutic strategies. Currently, veGF-a treatment 
is in clinical trial for patients with neurodegenerative dis-
ease (aMl). these and future clinical studies will finally 
show the potency of veGF family molecules in treatments 
for neurological disorders.
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